APA (7th ed.) Citation

JL, S., YJ, K., W, C., DS, L., HJ, G., AM, A. E., . . . TW, J. (2024). Interleukin 38 improves insulin resistance in hyperlipidemic skeletal muscle cells via PPARδ/SIRT1-mediated suppression of STAT3 signaling and oxidative stress. Biochemical and biophysical research communications, 722, 150158. https://doi.org/10.1016/j.bbrc.2024.150158

Chicago Style (17th ed.) Citation

JL, Sun, Kim YJ, Cho W, Lim DS, Gwon HJ, Abd El-Aty AM, Nas MA, Jeong JH, and Jung TW. "Interleukin 38 Improves Insulin Resistance in Hyperlipidemic Skeletal Muscle Cells via PPARδ/SIRT1-mediated Suppression of STAT3 Signaling and Oxidative Stress." Biochemical and Biophysical Research Communications 722 (2024): 150158. https://doi.org/10.1016/j.bbrc.2024.150158.

MLA (9th ed.) Citation

JL, Sun, et al. "Interleukin 38 Improves Insulin Resistance in Hyperlipidemic Skeletal Muscle Cells via PPARδ/SIRT1-mediated Suppression of STAT3 Signaling and Oxidative Stress." Biochemical and Biophysical Research Communications, vol. 722, 2024, p. 150158, https://doi.org/10.1016/j.bbrc.2024.150158.